2 studies found for:    23425163 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE
Condition: Venous Thromboembolism
Interventions: Drug: dabigatran etexilate 150 mg twice daily (BID);   Drug: matching placebo twice daily (BID)
2 Completed
Has Results
Secondary Prevention of Venous Thrombo Embolism (VTE).
Condition: Thromboembolism
Interventions: Drug: Dabigatran;   Drug: Warfarin

Indicates status has not been verified in more than two years